FORMA Therapeutics is a novel chemistry and integrated drug discovery platform for cancer therapies. Founded by Alexis Borisy, Nikolai Kley, and Steven Tregay in 2008, FORMA Therapeutics is backed by investors that include Wellington Management, RA Capital Management, EDBI, Cormorant Asset Management, and Samsara BioCapital and is headquartered in Cambridge.